Core Insights - The Vanguard Mega Cap Growth ETF (MGK) and Invesco QQQ Trust (QQQ) are both focused on large U.S. growth companies, particularly in the technology sector, with a comparison of costs, returns, risks, and portfolio compositions to assist investors in making informed decisions [2][4]. Cost & Size - MGK has a lower expense ratio of 0.07% compared to QQQ's 0.20%, which benefits fee-conscious investors [3][4]. - As of November 17, 2025, MGK's one-year return is 21.82%, slightly outperforming QQQ's 21.09% [3]. - MGK has an Assets Under Management (AUM) of $31.28 billion, while QQQ is significantly larger at $385.76 billion [3]. Performance & Risk Comparison - Over five years, MGK has a maximum drawdown of -36.02%, while QQQ has a drawdown of -35.12% [5]. - An investment of $1,000 would grow to $2,080 in MGK and $2,051 in QQQ over the same period, indicating MGK's marginally better performance [5]. Portfolio Composition - QQQ, launched in 1999, tracks the NASDAQ-100 Index with 101 holdings, primarily in technology (54%), communication services (17%), and consumer cyclical (13%) [6]. - MGK focuses on the 66 largest U.S. growth stocks, with similar sector allocations: 57% technology, 15% communication services, and 13% consumer cyclical [7]. - Both funds have significant overlap in top holdings, including major companies like Nvidia, Microsoft, and Apple, but MGK has slightly larger allocations to each [7][8]. Liquidity & Trading - QQQ is more liquid and has a larger number of stocks compared to MGK, which may appeal to investors seeking higher trading volumes [8]. - Both ETFs provide broad exposure to U.S. mega cap growth, although MGK's smaller number of holdings may lead to more concentrated exposures [8]. Investment Focus - Both MGK and QQQ target growth stocks with a strong emphasis on technology, which can yield above-average returns during tech market rallies but may also experience steeper declines during market volatility [10].

Group 1 - The article emphasizes the focus on identifying growth stocks, particularly in the biotech sector, with an emphasis on attractive risk/reward situations [1][2] - The Growth Stock Forum features a model portfolio of 15-20 stocks that are regularly updated, along with a top picks list of up to 10 stocks expected to perform well in the current calendar year [2] - The forum provides trading ideas targeting both short-term and medium-term market movements, along with community dialogue for discussions and questions [2]

Group 1 - The article emphasizes the focus on identifying growth stocks, particularly in the biotech sector, with an emphasis on attractive risk/reward situations [1][2] - The Growth Stock Forum features a model portfolio of 15-20 stocks that are regularly updated, along with a top picks list of up to 10 stocks expected to perform well in the current calendar year [2] - The forum provides trading ideas targeting both short-term and medium-term market movements, along with community dialogue for discussions and questions [2]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying stocks that can fulfill this potential is challenging [1] Group 1: Company Overview - OppFi Inc. (OPFI) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 97.5%, with projected EPS growth of 65.3% this year, significantly surpassing the industry average of 11.7% [5] Group 2: Financial Metrics - OppFi's year-over-year cash flow growth is 61.8%, well above the industry average of 5.8% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 19.4%, compared to the industry average of 14.1% [7] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for OppFi, with the Zacks Consensus Estimate for the current year increasing by 10.6% over the past month [8] - The combination of strong earnings estimate revisions and a Growth Score of B positions OppFi favorably for potential outperformance [10]

Group 1: Rubrik - Rubrik achieved a sales growth of 55% in the last quarter and is currently trading at 79 times free cash flow (FCF) [1] - The company is recognized as the No. 1 player in its niche, holding a "leader" designation from Gartner and has an impressive +80 Net Promoter Score, ranking it among the top 1% of enterprise software companies [1] Group 2: Rocket Lab - Rocket Lab's sales grew by 48% in the last quarter, and its next-generation Neutron rocket is expected to launch in the first quarter of 2026 [4] - The company holds a market cap of approximately $25 billion and is positioned as the No. 2 player in a space industry projected to exceed $1 trillion by 2035 [2] Group 3: Dutch Bros - Dutch Bros reported a 25% sales growth in the last quarter, but its stock has dropped by 33% from its all-time high due to decelerating revenue growth [7] - The company aims to expand to 2,029 total shops by 2029, doubling its current total, and is now funding store construction through its own cash flow [8] Group 4: Halozyme Therapeutics - Halozyme Therapeutics holds a near monopoly on subcutaneous drug deliveries, significantly reducing the time required for drug administration [9] - The company has increased sales by 38% annually over the last decade and is trading at 15 times FCF, indicating strong growth potential [10] Group 5: Global-e Online - Global-e Online facilitates international sales for brands, with its technology being utilized by major e-commerce platforms like Shopify [11] - Despite a 28% sales growth in the last quarter and a 40% drop in share price from its peak, the company remains a dominant player in its niche, trading at 42 times FCF [12] Group 6: Wingstop - Wingstop has experienced a decline in same-store sales for two consecutive quarters, leading to a 37% drop in its stock price [13] - Management believes the company can quadruple its store count, indicating potential for future growth despite recent challenges [15] Group 7: The Trade Desk - The Trade Desk's stock has fallen by 69%, but it still managed a 26% sales growth over the past year [16] - The company is trading at 25 times forward earnings, with improving adoption rates for its new AI-powered platform, Kokai [17] Group 8: Kinsale Capital - Kinsale Capital specializes in excess and surplus insurance lines, achieving 45% annualized net income growth over the last decade [18] - The company is currently trading at its lowest-ever P/E ratio of 19, making it an attractive investment opportunity [20] Group 9: SPS Commerce - SPS Commerce has delivered 99 consecutive quarters of sales growth but has guided for only 8% growth in 2026, resulting in a 59% drop in stock price [21] - The company trades at 21 times free cash flow, significantly below its five-year average, suggesting a potential buying opportunity [22] Group 10: MercadoLibre - MercadoLibre has shown a 39% sales increase in its last quarter and has become a core player in the Latin American economy with 77 million active e-commerce buyers [23] - The company is trading at 52 times forward earnings, which is considered reasonable given its strong growth trajectory [24]

Group 1 - The earnings season can be volatile, but long-term investors should look beyond single earnings reports and avoid impulsive buy-or-sell decisions [1] - Robinhood Markets and Uber Technologies experienced stock declines after their quarterly updates, yet both companies have outperformed broader equities this year and maintain strong prospects [2] Group 2 - Robinhood has evolved into a comprehensive financial services company, expanding from its initial trading app to include banking, advanced trading, and retirement savings accounts [4] - In Q3, Robinhood's revenue doubled to $1.27 billion, and earnings per share increased by 259% year over year to $0.61, but the stock fell due to high valuation concerns, trading at over 50 times forward earnings [5] - Robinhood is considered a buy for long-term investors due to its potential as a leading trading and financial services platform, appealing particularly to younger investors [6][7]

Core Insights - Companies mentioned are positioned for long-term growth despite recent stock price declines, presenting buying opportunities for investors [1][2] Duolingo - Duolingo's Q3 earnings report indicates strong growth with a significant increase in user sign-ups for its language learning app and new courses [3] - The stock has decreased by 64% from its peak due to lower-than-expected Q4 financial guidance, but management is focusing on user growth over immediate monetization [4] - Duolingo's market cap is $8 billion, with a gross margin of 71.39% and a year-over-year revenue growth of 41% [6][7] - Daily active users grew by 36% year-over-year, suggesting effective user engagement strategies [6] - The company's trailing-12-month free cash flow increased by 52% to $347 million, allowing shares to be purchased at a lower multiple of free cash flow [8] Take-Two Interactive - Take-Two Interactive is a leading video game producer with over $6 billion in trailing-12-month revenue, operating in a $200 billion industry [9] - The stock recently fell about 10% following a delay in the release of Grand Theft Auto VI, now scheduled for November 19, 2026 [10] - The delay is expected to enhance the game's quality, which is favorable for shareholders [10] - Take-Two's market cap is $43 billion, with a gross margin of 52.66% [11] - The company anticipates significant revenue growth post-release of Grand Theft Auto VI, with bookings projected to reach $10.8 billion by fiscal 2030 [12] - Take-Two's existing game lineup is already driving growth, with bookings up 33% year-over-year in fiscal Q2 [12][13]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates is challenging due to inherent risks and volatility [1] Group 1: Company Overview - Electromed, Inc. (ELMD) is highlighted as a promising growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 24.2%, with projected EPS growth of 25.9% this year, surpassing the industry average of 18.1% [4] Group 2: Financial Metrics - Electromed's year-over-year cash flow growth stands at 48.9%, significantly higher than the industry average of -2.4% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 12.7%, compared to the industry average of 6.3% [6] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for Electromed, with the Zacks Consensus Estimate for the current year increasing by 2.9% over the past month [7] - Electromed has achieved a Growth Score of A and a Zacks Rank of 2, indicating strong potential for outperformance [8]

Investment Strategy Focus - The report focuses on helping investors determine whether a value or growth stock investment strategy aligns with their financial goals and risk tolerance [1] - The analysis includes exploring key differences between value and growth stocks [1] - The report provides historical performance insights for both value and growth stocks [1]

Joining me now is Venu Krisha Barker's head of US strategy, equity strategy specifically. Thank you so much for being here with us. I'd love to talk about some of your changes. Let's talk about downgrading uh value to negative and your worries there.>> Yeah, I think you know we have been consistently positive on growth. So, and growth as you know is really dominated by technology where uh not just overall profitability but uh the scale of the beats of earnings continues. value other on the other hand has ex ...